GlassScriptPhysician profile
Renee Lea Ash
NPI 1497712467
$9,775.08
in general payments reported to CMS, 2019-2025
28 companies · $694 in 2025
The $694 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,533 · 2020: $611 · 2021: $1,869 · 2022: $3,320 · 2023: $1,217 · 2024: $531 · 2025: $694.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,442.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,442.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Legacy Ortho LLC | $3,616.00 | 2021-2022 | |
| Stryker Corporation | $2,441.01 | 2019-2024 | Citrefix, Viaflow, 7 X 23mm Citrelock Implant |
| Smith+Nephew, INC. | $884.59 | 2019-2025 | Stravix, Collagenase Santyl, Grafix Pl |
| Horizon Therapeutics Plc | $356.35 | 2019-2023 | Krystexxa |
| Treace Medical Concepts, INC. | $297.71 | 2022-2025 | |
| Imperative Care, INC | $290.24 | 2023 | Prodigy Catheter |
| Bone Support INC. | $252.17 | 2022-2025 | Cerament G, Ceramentbone Void Filler |
| Kerecis Limited | $164.79 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| In2bones USA, LLC | $154.17 | 2021 | |
| Wright Medical Technology, INC. | $150.61 | 2019 | |
| Zimmer Biomet Holdings, INC. | $148.90 | 2019-2020 | |
| Cardiovascular Systems INC. | $140.93 | 2021 | |
| Integra Lifesciences Corporation | $128.83 | 2019 | |
| Heron Therapeutics, INC. | $127.86 | 2021 | |
| Paragon 28, INC. | $114.89 | 2019-2020 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $104.39 | 2022 | |
| Kci USA, INC. | $87.29 | 2019-2020 | |
| Sanara Medtech INC. | $49.34 | 2022-2025 | Celleraterx |
| Misonix INC | $47.46 | 2020 | |
| Organogenesis INC. | $42.61 | 2022-2025 | Nushield |
| Bioventus LLC | $34.74 | 2020-2025 | Exogen Ultrasound Bone Healing System |
| Amgen INC. | $28.69 | 2024 | Krystexxa |
| Baxter Healthcare | $28.35 | 2019-2020 | |
| Solventum Corporation | $26.12 | 2025 | Activ.A.C. |
| Arteriocyte Medical Systems, INC. | $21.05 | 2022 | |
| Grt US Holding, INC. | $12.19 | 2021 | |
| Pfizer INC. | $12.08 | 2020 | |
| Bsn Medical INC | $11.72 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Renee Ash listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.